Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
758.80
Change Change %
5.70 0.76%

Updated:16 Nov, 2018, 14:24 PM IST

BSE
753.65
Change Change %
0.55 0.07%

Updated:16 Nov, 2018, 14:52 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Morgan Stanley
N/A
21-03-2014 Buy 867.00 1101.00
N/A
Closed Long (1Y)
21-03-2015

Morgan Stanley initiates overweight on IPCA Lab

Company steadily growing India formulations. Expect further ramp- up in antimalarials. Company will continue to have a healthy return on equity at more than 20 per cent. IPCA is a preferred healthcare mid-cap stock. 

Top